Tirzepatide 5mg
Dual-Action Weight Loss
View Certificate of AnalysisThird-party verified · 99.65% purityHPLC-UV by Testides (Toronto) · Lot TIRZ10-0626-01 · View COA →Compound Overview
✓ Lab results are in. Same compound and source as our 10mg lot, independently verified at 99.65% purity (HPLC-UV 214nm) by Testides — lot TIRZ10-0626-01, reported July 2, 2026. View the full certificate →
Tirzepatide is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. This 5mg vial is suited for researchers conducting dose-response calibration or initial protocol development with dual-agonist incretin compounds. Lyophilized at 99%+ verified purity.
Lab results: View COA (Testides) | Also available: Tirzepatide 10mg
See our Metabolic Peptide Comparison Guide.
Specifications
| Compound | Tirzepatide |
| Compound class | Dual GIP / GLP-1 receptor agonist peptide |
| CAS number | 2023788-19-2 |
| Molecular weight | 4,813.45 g/mol |
| Vial contents | 5 mg lyophilized powder |
| Reference lot | TIRZ10-0626-01 (same compound and source as the 10mg lot) |
| Verified purity | 99.65% (HPLC-UV, 214nm) |
| Testing laboratory | Testides, Toronto (ISO 17025-aligned) |
| Report date | July 2, 2026 — view certificate |
| Compatible solvent | Bacteriostatic water (0.9% benzyl alcohol) |
| Storage | Lyophilized: -20°C long-term, 2-8°C short-term |
| Research applications | Dual-incretin signalling, GIP and GLP-1 receptor pathways, glycaemic regulation, dose-response calibration studies |
| Related compounds | Tirzepatide 10mg, Semaglutide, Retatrutide |
| Ships from | British Columbia, Canada |
| Intended use | In-vitro laboratory research only |
Research Context & Mechanism+
Tirzepatide activates both GIP and GLP-1 receptors simultaneously. SURMOUNT-1 (Jastreboff et al., NEJM 2022, PMID: 35658024) and SURPASS-2 head-to-head vs semaglutide (Frías et al., NEJM 2021, PMID: 34170647) established the dual-agonist mechanism as a distinct research avenue.
Purity & Third-Party Testing+
Tested by Testides (Toronto) — HPLC-UV for purity, mass spectrometry for identity. This compound's current lot (TIRZ10-0626-01) returned 99.65% purity, reported July 2, 2026. View the certificate of analysis →
Storage & Handling+
Lyophilized: -20°C long-term, 2-8°C short-term.
Shipping & Delivery+
Ships from BC. Tracked Canada-wide. Shipping policy →
Returns & Refunds+
Contact info@thepeptide.ca within 48 hours for damaged orders. Refund policy →
For laboratory and research use only. Not for human consumption, veterinary use, or therapeutic application. Not approved by Health Canada.
- Sealed vial: −20°C, 24+ months.
- Protect from light and heat.
- Keep in original packaging until use in the laboratory.
- CAS: 2023788-19-2
- Molecular weight: 4,813.45 g/mol
- Class: Dual GIP / GLP-1 receptor agonist
- Purity: ≥99% (HPLC)
Not for human or animal use. We do not publish preparation, dilution or administration guidance of any kind.
By purchasing, you confirm research intent and accept full responsibility for compliance.
YOU MAY ALSO LIKE
SHOP ALL
Frequently Bought Together
Laboratory supplies commonly ordered alongside research compounds.
Bacteriostatic Water 10mL — Sterile Multi-Use Laboratory Water with 0.9% Benzyl Alcohol
Essential Reconstitution Supply
STARTING AT ▸ $22.00
Insulin Syringes 10-Pack — 1mL, 29G × ½" Sterile Single-Use Laboratory Syringes
Sterile. Ultra-fine. Individually wra...
Why ThePeptide
Most research peptide sellers ask you to take their word for it. We publish the receipts.
